An agreement is signed with Professor Trevor Archer, to continue, as research manager for the next three years.

A new patent application is filed, YEAST FOR THE TREATMENT OF ALLERGY. The patent application was based on an (in vivo) allergy study conducted in 2017 and in vitro studies at Sapienza University.

Sapienza reports in vitro studies showing that the dry form of Milmed shows the same and partly better results than Milmed as a suspension.

Professor Businaro reports in vitro studies showing that Milmed has no toxicity and Milmed is harmless towards animals, humans and plants.

A renewed research agreement has been signed with Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies. The research leader is still Professor Rita Businaro, and she’s looking forward to continuing her research.